AGTC: Applied Genetic Technologies : Termination of Material Agreement - Form 8-K
(marketscreener.com) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 ...https://www.marketscreener.com/quote/stock/APPLIED-GENETIC-TECHNOLOG-16113742/news/Applied-Genetic-Technologies-Termination-of-Material-Agreement-Form-8-K-42453880/?utm_medium=RSS&utm_content=20221201
Read full article »
AGTC is a Florida-based biotechnology company that researches and develops gene therapies for the treatment of ocular diseases.
Read more